We Are Solutions...On Demand

Youtube Facebook Twitter LinkedIn

Recent News

PROTEIN BIOMARKER PRODUCER REVOLUTIONIZES EARLY DETECTION OF STOMACH CANCER

Lee Biosolutions, is a manufacturer and producer of high purity proteins announces a major scientific breakthrough. The St. Louis-based biotechnology firm recently developed a proprietary process to effectively and efficiently purify and stabilize two important gastric cancer protein biomarkers. As a result, they are producing Pepsinogen I and Pepsinogen II, critical components in serum pepsinogen tests that will revolutionize early detection of stomach and gastric cancer.

According to American Association for Cancer Research (AACR), stomach cancer is the second-leading cause of cancer-related deaths worldwide and the top cause in Eastern Asia, which comprises China, Japan, Taiwan and Korea. Studies have shown that if the disease is detected early, patients five-year survival rates increases by 90 percent. Asian and European governments have been advocating mass screenings for decades, but traditional upper endoscopy procedures are painful, invasive and expensive. Lee Biosolutions proteins Pepsinogen I and Pepsinogen II production capabilities enables international diagnostics companies to quickly manufacture serum pepsinogen tests, which are affordable and easy to administer. Lee has scaled up production to meet global market demand.

“Gastric cancer screening involves H Pylori infection detection, measurement of serum pepsinogen I and II levels and possibly endoscopic examination.  ,” said Burton Lee, president of Lee Biosolutions. “The challenge to-date for diagnostic companies  has been producing  tests efficiently and affordably. Recently, Lee Biosolutions research and development team cracked the code for purifying and stabilizing two very important gastric and stomach cancer protein biomarkers, Pepsinogen I and Pepsinogen II, primary components in serum pepsinogen tests. We now have the expertise, processes and manufacturing capacity to produce enough of these biomarkers to make a significant impact.”

Serum pepsinogen tests for gastric cancer enable healthcare providers to identify high risk patients for further monitoring. Not only do the tests increase survival rates by 90 percent but they also decrease the cost of mass screening programs. Lee currently has clients in Eastern Asia and Europe that plan to produce, distribute and administer the tests.

About Lee Biosolutions, Inc.
Lee Biosolutions is an international producer of high purity human, animal and recombinant proteins, biological fluids, biochemicals, antibodies and immunoreagents. Headquartered in St. Louis and founded in 1975, the biotechnology firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee Biosolutions produces and processes the raw biomaterials used in drug discovery and development, laboratory equipment calibration, clinical diagnosis and product testing. These include human neutrophil elastase, human myeloperoxidase isoform c, alpha fetoprotein, beta 2 microglobulin, and amylase. The company is ISO 9001:2008 certified, FDA registered and meets USDA guidelines. To learn more about Lee Biosolutions visit www.LeeBio.com .

SERUM TUMOR MARKERS FOR MANAGEMENT OF TESTISCULAR GERM CELL TUMORS

Lee Biosolutions Inc, a U.S. manufacturer, producer and supplier of high purity proteins and antigens announces the isolation and increased production of Serum Tumor Markers for the management of testicular germ cell tumors. The St. Louis-based healthcare- biotechnology firm has developed a unique proprietary process to effectively and efficiently purify beta Human Chorionic Gonadotropin, Alpha fetoprotein and Lactate dehydrogenase. As a result, Lee is now is a preferred producer for researchers and diagnostic companies to supply these critical components that are used in early detection of testicular cancer.

According to the American Cancer Society, there will be almost 9000 new cases of testicular cancer diagnosed in the United States this year. Although the rate of testicular cancer is rising for unknown reasons worldwide the death rate is low because of early detection and advances in the treatment of testicular cancer. Testicular cancer can develop in one or both testicles with over 90 percent of cancers in the testicle develop in special cells known as germ cells. Germ cells Scientists have found few risk factors that make a man more likely to develop testicular cancer.

Lee’s testicular germ cell tumor marker production capabilities enables in vitro diagnostics companies to manufacture diagnostic tests , which are affordable and easy to administer. Lee has scaled up production to meet global market demand. Beta Human Chorionic Gonadotropin (Beta HCG), alpha fetoprotein (AFP ) and Lactate Dehydrogenase (LDH) produced by Lee Biosolutions are used in the management of testicular germ cell tumors.

“Lee Biosolutions is on the forefront of Testicular Cancer research by supplying highly purified markers such as beta HCG, alpha fetoprotein and lactate dehydrogenase. Most testicular cancers are found by men themselves. If a lump is detected the doctor would recommend blood tests to determine levels of tumor markers to determine the proper diagnosis. Testicular cancer is survivable if treated early enough by the removal of the testicle. Its when you ignore the signs and you find yourself with Stage III cancer that has spread to the lungs, liver, bones and brain that survival rates diminish,” said Burton Lee, President of Lee Biosolutions.

Lee BioSolutions is an international producer and supplier of high purity finished proteins. Headquartered in St. Louis and founded in 2002, the healthcare biotechnology firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee BioSolutions produces and processes raw biomaterials used in drug discovery and development, diagnostic controls and calibrators, clinical diagnosis and product testing. The company is ISO 9001:2008 certified, FDA registered and meets USDA guidelines. For more information go to Lee Biosolutions website at leebio.com

PROTEIN BIOMARKER PRODUCER REVOLUTIONIZES CARDIOVASCULAR RESEARCH

Lee Biosolutions Manufactures   Myeloperoxidase  and CRP, Key Prognostic Markers of Inflammation of  Cardiovascular Disease

ST. LOUIS , MO  Lee Biosolutions Inc, an international manufacturer, producer and supplier of high purity proteins and antigens announces the isolation and increased production of Myeloperoxidase isolated from Leukocytes and C-Reactive Protein from Pleural Fluid.   The St. Louis-based  biotechnology firm has  developed a unique  proprietary process to effectively and efficiently purify  the  Myeloperoxidase and C-Reactive Protein  used in the prediction of Cardiovascular Disease. As a result, Lee is now is a preferred producer for researchers and  diagnostic companies to supply these critical components .

According to the Centers of Disease and Control, over 40% of all deaths in the United States are attributed to Cardiovascular Disease which means over 1 million of us die every year.  Several risk factors are used by doctors to determine the risk of developing CVC and what better way to access an individual than to test and predict that they will have cardiovascular disease.

LeeBio’s new  Myeloperoxidase and C-Reactive Protein production capabilities enables international diagnostics companies  to quickly manufacture diagnostic tests , which are affordable and easy to administer. Lee has scaled up production to meet global market demand.

“Lee Biosolutions is on the forefront of Cardiovascular  research  by supplying  highly purified  markers such as C-Reactive Protein and  Myeloperoxidase .  “ said Burton Lee, President of Lee Biosolutions  . “  You will find the future of clinical diagnostics will utilize a greater number of  combination of biomarkers to predict early clinical diagnosis of diseases as they are identified.”

About Lee Biosolutions, Inc.
Lee Biosolutions is an international producer and supplier of high purity finished  human proteins.  Headquartered in St. Louis and founded in 2002, the biotechnology firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee BioSolutions produces and processes the raw biomaterials used in drug discovery and development, laboratory equipment calibration, clinical diagnosis and product testing. These include Low Denisity Lipoprotein (LDL),High Denisity Lipoprotein (HDL), CkMB and Troponin,  The company is ISO 9001:2008 certified, FDA registered and meets USDA guidelines. To learn more about Lee Biosolutions visit www.LeeBio.com or call 314-968-1091.

LEE BIOSOLUTIONS HELPS MAKE CANCER PATIENT’S WISH COME TRUE

MEDIA CONTACT
Rich Meyer
Swell Advertising
314.825.8503
rmeyer@swelladvertising.com

FOR IMMEDIATE RELEASE

Lee Biosolutions helps make cancer patient’s wish come true

St. Louis, MO—Lee Biosolutions is in the business of fighting cancer. The Brentwood-based company produces finished proteins, enzymes, biologicals, immuno-reagents and antibodies for life science research and clinical diagnostic testing. So when company president Burton Lee heard of cancer patient Michelle W.’s wish, helping grant it just made sense.

“Everything we do here at Lee Biosolutions is about cancer,” Lee said. “Fighting it, finding ways to detect it earlier, lessening its impact on human lives… As an extension of that, I’ve been looking for ways to reach out to cancer victims and their families—and to other organizations involved in the fight.”

Michelle is one person he’s reached out to and helped. The 37-year-old mother of two was recently diagnosed with brain cancer. Her prognosis is that she could survive six months or less. Her wish, made through the not-for-profit foundation 3 Little Birds 4 Life, was to take her family to Disney World. Michelle wants “to make amazing memories” for her husband Dan and their children, six-year-old Liliana and four-year-old Milo. Through its community outreach program, Lee Biosolutions is making Michelle’s wish come true, picking up the tab for the entire $8,000 trip.

Lee first learned of 3 Little Birds 4 Life from his Senior Protein Chemist, Dr. Melanie McGill. “Melanie designs jewelry and sells it at the boutique Schön, in Richmond Heights. Once a month, Schön sponsors a different not-for-profit organization, and part of the sales go to that organization. Melanie met Ashley Swip, founder of 3 Little Birds 4 Life, at a Schön event.”

Swip founded the Collinsville, Illinois-based organization shortly after her own brother died of cancer at the age of 28. In trying to find a way to make her brother’s last days more memorable, Swip discovered that while there are organizations focused on helping children and seniors with terminal cancer, there was nothing specifically for young adults. She created 3 Little Birds 4 Life to help cancer patients between the ages of 18 and 40.

Sending Michelle and her family to Disney World isn’t the only wish Lee Biosolutions has helped grant. Lee and his employees also volunteered to build a deck for one of 3 Little Birds 4 Life’s wish recipients.

“We’re constantly working to find new ways to fight cancer,” Lee said. “And we’re good at it. We’ve developed a proprietary process to purify and test for novel cancer biomarkers. But we always want to be doing more. Helping improve the lives of cancer patients, even in small ways, is one way we can.”

About Lee BioSolutions, Inc.

Lee BioSolutions is an international producer and supplier of high purity finished proteins. Headquartered in St. Louis and founded in 2002, the healthcare biotechnology firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee BioSolutions produces and processes raw biomaterials used in drug discovery and development, laboratory equipment calibration, clinical diagnosis and product testing. The company is ISO 9001:2008 certified, FDA registered and meets USDA guidelines.

www.leebio.com

EARLY DETECTION OF ALCOHOLIC LIVER DISEASE

Lee Biosolutions Inc, a U.S. manufacture of high purity finished proteins has increased production capacity for important enzymes used in liver function blood tests worldwide. The St. Louis-based healthcare- biotechnology firm has been able to keep up with demand for aminotransferase enzymes by increasing yields through newly developed purification methodologies.

The liver is not only the largest organ but the largest gland in the human body which plays an important role by filtering and processing blood as it circulates through the body. The functions of the liver include detoxification of your blood, production of important clotting factors and other proteins, processing nutrients, waste products of hemoglobin and storing vitamins, cholesterol and bile while also producing glucose. The cells in the liver contain proteins called enzymes that drive these chemical reactions. When the liver cells are damaged or destroyed, the enzymes in the cells leak out to the blood where they can be measured by blood tests. The liver function tests include measuring two main enzymes, Aspartate Aminotransferase called AST (GOT) and Alanine Aminotransferase ALT (SGPT) which when elevated is a strong sign of liver damage or disease.

According to Burton Lee, President of Lee Biosolutions, “The enzymes that are produced for liver function tests are actually isolated from porcine and bovine sources at our facility in St. Louis. Our production chemists process literally thousands of kgs of high quality tissue from USDA slaughter houses at a time in order to isolate and purify just a few hundred grams of a single enzyme. Careful monitoring of critical points in the process is needed to insure a stable high quality product. Our finished enzymes are then purchased under strict specifications by major IVD companies such as Bio-Rad Laboratories who produce the reagents and blood tests for hospitals to aid in the diagnoses if someone has alcoholic liver disease, viral hepatitis, and acute or chronic liver injury. Its very satisfying to know the products that you produce are helping save lives.”

About Lee Biosolutions, Inc.
Lee Biosolutions is an international producer high purity finished proteins. Headquartered in St. Louis and founded in 2002, the healthcare biotechnology firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee BioSolutions produces and processes proteins and antibodies used in drug discovery and development, clinical diagnostic and immunodiagnostic market. The company is ISO 9001:2008 certified, has an active fan base on facebook ,is FDA and APHIS certified. To learn more about Lee BioSolutions visit http://www.LeeBio.com.

TRANSFORMING THE WAY KILLER BLOOD CLOTS ARE DETECTED

Lee BioSolutions Supplies D-Dimer , Key Component of Deep Vein Thrombosis Detection and Pulminary Embolism to major diagnostic companies worldwide

ST. LOUIS , MO Lee BioSolutions, an international manufacturer, producer and supplier of high purity proteins and antigens announces an increased in supply of D-Dimer protein. The St. Louis-based biotechnology firm recently developed a proprietary process to effectively and efficiently purify the marker for Deep Vein Thrombosis and Pulmonary Embolism. As a result, Lee is supplying bulk quantities of this critical components for thrombosis tests to major manufacturers for early detection of blood clots to prevent DVT.

According to the Centers of Disease and Control, CDC, , Deep Vein Thrombosis and Pulmonary Embolism affects up to 600,000 individuals in the US alone each and every year . What happens in the most serious of cases is Deep Vein Thrombosis or DVT when part of a blood clot breaks off in the leg and travels through the bloodstream to the lungs causing a blockage called pulmonary embolism. DVT/PLE shows no preference to age, gender or ethnicity and is one of those disorders that is repeatedly underdiagnosed causing serious illness, disability and even death. In fact 10% of individuals diagnosed with DVT will die within the first month of diagnosis because they were not treated early enough. With risk factors such as aging population , more sedentary habits among individuals and obesity , this disorder is becoming an important and growing public health concern.

Lee’s new D-Dimer production capabilities enables international diagnostics companies to quickly manufacture serum D-Dimer tests, which are affordable and easy to administer. Lee has scaled up production to meet global market demand.

“Lee Biosolutions is on the forefront of Coagulation disorders and Deep Vein Thrombosis research by supplying a highly purified clot dissolving substance call D-Dimer from human serum “ said Burton Lee, President of Lee Biosolutions . “ D-Dimer test is used for detecting increased D dimer in your blood is most useful for ruling out deep vein thrombosis or for identifying people at risk of recurrence. “

Lee Biosolutions is also involved with early detection of Diabetes with our new HbA1c and detection of Chronic Kidney Disease with cystatin C protein . We are all about saving lives with early detection of clinical diseases.

About Lee Biosolutions, Inc.
Lee Biosolutions is an international producer and supplier of high purity human, animal and recombinant proteins, biological fluids , antibodies and immunoreagents. Headquartered in St. Louis and founded in 1981, the biotechnology firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee Biosolutions produces and processes the raw biomaterials used in drug discovery and development, laboratory equipment calibration, clinical diagnosis and product testing. These include human neutrophil elastase, human myeloperoxidase isoform c, alpha fetoprotein, beta 2 microglobulin, and amylase. The company is ISO 9001:2008 certified, FDA registered and meets USDA guidelines. To learn more about Lee BioSolutions visit www.LeeBio.com or call 314-968-1091.

PROTEIN BIOMARKER PRODUCER DECLARES WAR ON SILENT KILLER

Saint Louis, MO Lee Biosolutions Inc, is an international manufacturer, producer and supplier of high purity biomarkers used in the prediction, prevention and management of cardiovascular diseases known as CVD. The St. Louis-based biotechnology health care firm has developed a unique proprietary process to effectively and efficiently purify Biochemical Biomarkers such as Low Density Lipoprotein (LDL) and High Density Lipoprotein(HDL) from Human Plasma used by manufacturers of lipid profile blood tests. As a result, Lee is now is a preferred producer for clinical researchers and diagnostic companies around the world to supply these critical components .

According to the World Health Organization located in Switzerland, 30% of all global deaths are attributed to CVD which encompasses a group of disorders of the heart and blood vessel. These disorders include coronary heart disease, cerebrovascular disease, peripheral arterial disease , rheumatic heart disease, congenital heart disease and deep vein thrombosis and pulmonary embolism.
Lee’s cholesterol products, Low Density Lipoprotein and High Density Lipoproteins are carefully isolated from human plasma and are supplied to international diagnostic companies to produce quality diagnostic tests for Cholesterol ,HDL,LDL and Triglycerides. As a result, Lee has hired additional scientists to meet global market demand.

Burton Lee , President of Lee Biosolutions says, Cholesterol itself is not a problem but its when you have high levels of cholesterol and LDL is when you run into trouble. Too many people think of cholesterol as something bad but in actuality you need cholesterol for the synthesis of vitamin D and hormones in your body. Cholesterol is needed to help with fat absorption molecules by converting to bile in your digestive tract. One way to manage your health is to get a lipid profile test and that’s where we come in. We are the supplier of these analytes that go into these blood tests. We also see another promising set of biomarkers that will be very popular for heart disease management and they are Pro-BNP and NT-proBNP which we are offering . “

About Lee Biosolutions, Inc.
Lee Biosolutions is an international producer and supplier of high purity finished human proteins. Headquartered in St. Louis and founded in 2002, the biotechnology healthcare firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee Biosolutions produces and processes the raw biomaterials used in drug discovery and development, laboratory equipment calibration, clinical diagnosis and product testing. These include Low Denisity Lipoprotein(LDL),High Density Lipoprotein(HDL), CkMB and Troponin, Myeloperoxidase, C-Reactive Protein and NT-proBNP, The company is ISO 9001:2008 certified, FDA registered and meets USDA guidelines. To learn more about Lee BioSolutions visit http://www.LeeBio.com or call 314-968-1091.

FIGHTING A WAR WITH PROSTATE CANCER

Lee BioSolutions Inc, an international manufacturer and producer of high purity proteins and antigens announces the isolation and increased production of Acid Phosphatase and Prostate Specific Antigen. The St. Louis-based healthcare- biotechnology firm has developed a unique proprietary process to effectively and efficiently purify the prostate cancer Tumor Marker PSA and its isoforms. As a result, Lee is now is a preferred producer for researchers and diagnostic companies to supply these critical components .

According to the National Cancer Institute, there is an estimated 241,000 new cases of prostate cancer in the United States along and 28,000 men will not survive this year . There is over 2.5 million men who are currently living with the disease.

Lee’s Prostate Specific Antigen production capabilities enables international diagnostics companies to quickly manufacture diagnostic tests , which are affordable and easy to administer. Lee has scaled up production to meet global market demand. PSA protein that is produced by Lee Biosolutions is used in diagnostic tests which help in the diagnosis, to assess the patiences response to treatment, and allows Docters to look for recurrence.

“Lee Biosolutions is on the forefront of Prostate Cancer research by supplying highly purified markers such as PSA and its isoforms . A PSA Test measures the level of PSA in the blood and is one of the tools used for screening men with prostate cancer. With continued improvements in screening, diagnosis and treatment of prostate cancer more men are living with the disease .” said Burton Lee, President of Lee Biosolutions.

About Lee Biosolutions, Inc.
Lee Biosolutions is an international producer and supplier of high purity finished proteins. Headquartered in St. Louis and founded in 2002, the healthcare biotechnology firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee Biosolutions produces and processes raw biomaterials used in drug discovery and development, laboratory equipment calibration, clinical diagnosis and product testing. These include Alpha FetoProtein used in detection of liver cancer and germ cell tumors,Beta 2 Microglobulin used to detect multiple myeloma, chronic lymphocytic leukemia and some lyophomas, Thyroglobulin for detecting Thyroid Cancer, and Lactate Dehydrogenase used to assess state and prognosis of Germ cell tumors.    The company is ISO 9001:2008 certified, FDA registered and meets USDA guidelines. To learn more about Lee Biosolutions visit http://www.LeeBio.com or call 314-968-1091.

BLOOD CELL CANCER MARKERS MAKING A DIFFERENCE

 

ST. LOUIS , MO  Lee Biosolutions Inc, an international manufacturer, producer and supplier of high purity finished proteins and antigens announces  increased production of  beta 2 MICROGLOBULIN .   The St. Louis-based  healthcare- biotechnology firm has  developed a unique  proprietary process to effectively and efficiently purify  B2M in bulk.  As a result, Lee is now is a preferred producer for researchers and  diagnostic companies to supply  this critical tumor marker for multiple myelomas and lymphomas.

Beta 2 MICROGLOBULIN is an important blood plasma protein used for detecting some blood cell cancers as lymphomas and multiple myelomas and for detecting kidney damage. B2M is used for prognosis because it is found on the surface of many cells, including lymphocytes, and in small amounts in the blood and urine. According to the CDC, there are over 10,000 deaths of multiple myeloma per year and over 20,000 people dying from lymphoma just in the United States alone. Lymphoma is the most common form of blood cancer in the developed world.

“ We feel that Lee Biosolutions is on the forefront of Blood Cell Cancer research  by supplying  highly purified  markers such as Beta 2 Microglobulin to the research community and clinical diagnostic market.  A B2M Test measures the level of B2M in the blood  or urine and is one of the tools used  for identifying disease activity and tumor burden.  With continued  improvements in screening, diagnosis and treatment of blood cancers and kidney damage  more individuals are able to manage their disease earlier and live longer .”  said Burton Lee, President of Lee Biosolutions.

About Lee BioSolutions, Inc.
Lee BioSolutions is an international producer and supplier of high purity finished   proteins.  Headquartered in St. Louis and founded in 2002, the healthcare biotechnology firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee BioSolutions produces and processes finished and intermediate proteins  used in drug discovery and development , clinical diagnosis and product testing. These include Alpha Feto Protein used in detection of liver cancer and germ cell tumors, Beta 2 Microglobulin used to detect multiple myeloma, chronic lymphocytic leukemia and some lyophomas,  THYROGLOBULIN for detecting Thyroid Cancer,   and Lactate Dehydrogenase used to assess state and prognosis of Germ cell tumors.    The company is ISO 9001:2008 certified, FDA registered and approved by APHIS for exporting . To learn more about Lee BioSolutions visit www.LeeBio.com or call 314-968-1091.

LEE BIOSOLUTIONS, INC TO SUPPLY THE HIGHEST QUALITY HEMOGLOBIN A1C TO THE DIABETES MARKET

Lee BioSolutions Inc, an international manufacturer, producer and supplier of high purity proteins and antigens announces that it will supply high purity Hemoglobin A1C to the Diabetes Market. Hemoglobin A1C is isolated from Red Blood cells and is used as an indicator of blood glucose in a diabetic patient. The A1C test is an important test in the diagnosis and management of diabetes.

According to the World Health Organization there are over 350 million people who have diabetes worldwide. Current news reports say that 50% of individuals living in the United States are either pre-diabetic or diabetic.

Lee Biosolutions recognizes the growing diabetes market and is committed in providing the highest quality Hemoglobin A1C protein and is working closely with major diagnostic companies to meet demand of this highly desirable indicator. . In addition to isolating A1C from red blood cells, Lee Biosolutions is also providing prediabetic, diabetic Type 1 and diabetic Type 2 urine from donors.

“Lee Biosolutions is on the forefront of Diabetes research by supplying highly purified markers such as Hemoglobin A1C,“ said Burton Lee, President of Lee Biosolutions . “ What is unique about this test is that patients do not need to fast as with the common fasting plasma glucose test. Since HbA1C builds up in red blood cells throughout the lifetime of diabetic patients, its levels represent an excellent record of blood glucose levels over the previous 2-3 months. We are happy to be a part of early diagnosis of a disease that is so common but is taken so much for granted.“

About Lee BioSolutions, Inc.
Lee BioSolutions is an international producer and supplier of high purity finished human proteins. Headquartered in St. Louis and founded in 2002, the biotechnology firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee BioSolutions produces and processes the raw biomaterials used in drug discovery and development, laboratory equipment calibration, clinical diagnosis and product testing. These include Low Denisity Lipoprotein (LDL),High Denisity Lipoprotein(HDL), Myeloperoxidase, C-Reactive Protein, CkMB and Troponin, The company is ISO 9001:2008 certified, FDA registered and meets USDA guidelines. To learn more about Lee BioSolutions visit http://www.LeeBio.com or call 314-968-1091.

More